BeOne Medicines Ltd
41 hedge funds and large institutions have $221M invested in BeOne Medicines Ltd in 2016 Q1 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$54.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.6M |
| 3 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$19.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.8M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
+$11.8M |
Top Sellers
ONC Hedge Fund Activity: Q1 2016 in Review
41 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2016, worth a combined $221M.
Buyers outnumbered sellers: 41 funds opened new ONC positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $54.2M.
- 41 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2016, up from 0 in Q4 2015.
- Funds reported $221M of BeOne Medicines Ltd stock for Q1 2016.
- 41 funds opened new BeOne Medicines Ltd positions in Q1 2016 and 0 closed out, a net change of +41 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2016 was Baker Bros. Advisors, an estimated $54.2M added.
Based on aggregated 13F filings for Q1 2016.